Randomized Controlled Crossover Trial of Postpyloric Feedings to Improve Pulmonary Outcomes in High-risk Preterm Infants - Trial NCT05777512
Access comprehensive clinical trial information for NCT05777512 through Pure Global AI's free database. This phase not specified trial is sponsored by Boston Children's Hospital and is currently Not yet recruiting. The study focuses on Bronchopulmonary Dysplasia. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Boston Children's Hospital
Timeline & Enrollment
N/A
Apr 01, 2023
Feb 01, 2026
Primary Outcome
Change in modified respiratory severity score (mRSS),Tracheal Aspirates
Summary
The purpose of this study is to determine if postpyloric feedings effectively improve
 objective measures of pulmonary health in preterm infants with chronic lung disease when
 compared with nasogastric (NG) feedings. This research will (1) determine the optimal
 nutritional management to prevent a common and costly complication of prematurity, and (2)
 use a novel crossover design that examines outcomes of clinical endpoints alongside
 biomarkers.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05777512
Non-Device Trial